The Vanguard Group 13D and 13G filings for Myriad Genetics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-29 1:54 pm Sale |
2025-06-30 | 13G | Myriad Genetics, Inc. MYGN |
The Vanguard Group | 9,257,493 10.040% |
-696,740 (-7.00%) |
Filing |
| 2024-02-13 5:09 pm Purchase |
2023-12-29 | 13G | Myriad Genetics, Inc. MYGN |
The Vanguard Group | 9,954,233 11.120% |
642,472 (+6.90%) |
Filing |
| 2023-02-09 11:27 am Purchase |
2022-12-30 | 13G | Myriad Genetics, Inc. MYGN |
The Vanguard Group | 9,311,761 11.490% |
162,240 (+1.77%) |
Filing |
| 2022-02-10 08:27 am Purchase |
2021-12-31 | 13G | Myriad Genetics, Inc. MYGN |
The Vanguard Group | 9,149,521 11.460% |
852,657 (+10.28%) |
Filing |
| 2021-02-10 11:28 am Sale |
2020-12-31 | 13G | Myriad Genetics, Inc. MYGN |
The Vanguard Group | 8,296,864 11.030% |
-23,710 (-0.28%) |
Filing |